Category: Board of Trustees

Michal Zahradníček, M. Eng., MBA

Michal Zahradníček, one of the founders of PrimeCell Therapeutics, is an investor and acts as a key figure in several high-tech companies in the Czech Republic and the Central and Eastern European region. He began his career in 1993, working as an economist for several international companies. Since 2001, he has been involved in investments…
Read more

Search for:

News

Rozhovor s Prof. MUDr. Jakub Hort, Ph.D: Alzheimer trápí 120 tisíc Čechů, odhalen bývá pozdě.
Primecell poprvé investuje do umělé inteligence v medicíně. Vybrala si Alzheimera
Grant Exclusive Distribution License for AMNIODERM+® in Turkey
INTERVIEW MARTIN ZIKA WITH IVETA SCHMIEDOVA MGR.
AMNIODERM+ CLINICAL TRIAL SUCCESSFULLY COMPLETED

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Enable or Disable Cookies

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

Category: Board of Trustees

Václav Jirků, MD

Ivo Kristen, M. Eng.

Michal Zahradníček, M. Eng., MBA

News